 |
This Congress has been declared free of tobacco smoke |
 |
Buenos Aires, Capital of Book 2011 |
 |
 |
| Official Domestic Carrier | Official International Carrier |
 |
MCI Buenos Aires Avenida Santa Fe 1970, 1º Piso, Oficina 1 C1123AAO, Buenos Aires, Argentina Phone: +54 11 5252 9801 / Fax: +54 11 4813 0073 e-mail - Web |
EspañolRegular Symposia
RS1. COGNITIVE REMEDIATION THERAPY IN SCHIZOPHRENIA: STATE OF THE ART
(September 19, 9.00-10.30)
RS1.1 Integrated approaches to treating neurocognition and social cognition
A. Medalia (USA)
RS1.2 Efficacy of integrated cognitive remediation therapy approaches in schizophrenia
V. Roder, S.J. Schmidt, D.R. Mueller (Switzerland)
RS1.3 Social cognitive remediation therapy
D.L. Roberts (USA)
RS1.4 Neurocognitive remediation approaches in the treatment of schizophrenic patients
I. Fuentes, J.C. Ruiz, C. Dasí, M. Soler (Spain)
RS2. THE ECONOMIC COLLAPSE OF ICELAND IN 2008: MENTAL HEALTH CONSEQUENCES IN A REGIONAL CONTEXT
(September 19, 9.00-10.30)
RS2.1 Emergency visits and use of primary care and psychiatric services during the financial crisis in Iceland
H. Olafsdottir (Iceland)
RS2.2 Impact of economic collapse on bed usage in psychiatry in Iceland
E. Sigurdsson (Iceland)
RS2.3 The pattern of drug use and drug-related admissions to psychiatric wards after the financial crisis in Iceland
A. Magnusson (Iceland)
RS2.4 The economic collapse of Iceland in 2008: mental health consequences in a regional context
P. Matthiasson (Iceland)
RS3. IMAGES OF PSYCHIATRY: IMPROVING THE PERCEPTION OF PSYCHIATRY AMONG THE GENERAL PUBLIC AND OTHER MEDICAL PROFESSIONALS
(September 19, 9.00-10.30)
RS3.1 Recruitment into psychiatry: challenges and solutions
K.A. Seed, G. Lydall, A. Malik, R. Howard, D. Bhugra (UK)
RS3.2 Stigmatization of psychiatry and psychiatrists: results of an international control-group study
W. Gaebel, K. Samjeske, J. Zielasek (Germany)
RS3.3 Images of psychiatry – a Royal College of Psychiatrists campaign 2005-2008
S. Hollins (UK)
RS4. MERGING EVIDENCE AND CLINICAL PRACTICE IN THE MANAGEMENT OF DEPRESSION: THE CANMAT EXPERIENCE
(September 19, 10.45-12.15)
RS4.1 Psychotherapy alone or in combination with antidepressants for major depression
S. Parikh (Canada)
RS4.2 CANMAT clinical guidelines for the management of major depressive disorder: advances in pharmacotherapy for depression
R. Lam (Canada)
RS4.3 Neurostimulation therapies for the management of major depressive disorders in adults: evidence and recommendations
R. Milev (Canada)
RS4.4 Complementary and alternative treatments for major depression: a review
A. Ravindran (Canada)
RS5. CURRENT KNOWLEDGE ON THE BEHAVIORAL TRIGGERS AND UNDERLYING BIOLOGY OF SUICIDE
(September 19, 10.45-12.15)
RS5.1 Personalized medicine and the risk of suicide: problems and promises
C. Nemeroff (USA)
RS5.2 Cortisol response to a pharmacologic challenge: a marker of future suicide attempt risk
J.G. Keilp, M.A. Oquendo, B.H. Stanley, A.K. Burke, T.B. Cooper, K.M. Malone, J.J. Mann (USA)
RS5.3 Suicide behavior, its endophenotypes and the HPA axis
D. Wasserman, Y. Ben-Efraim, J. Wasserman, M. Sokolowski (Sweden)
RS5.4 Differential hippocampal promoter methylation associates with suicide
B. Labonté, M. Suderman, N. Mechawar, M. Szyf, M. Meaney , G. Turecki (Canada)
RS6. GENIUS, ARTS AND PSYCHIATRY
(September 19, 10.45-12.15)
RS6.1 Creativity, depression and psychotherapy: the case of the statesman, scientist and poet J.W. Goethe
R. Holm-Hadulla (Germany)
RS6.2 Robert Schumann: the price of creativity
A. Heerlein (Chile)
RS6.3 Melancholy and creativity: the case of Rainer Maria Rilke
O. Doerr (Chile)
RS6.4 Who owns the works of art created by mentally ill people
J.J. López-Ibor Jr. (Spain)
RS7. FROM PAPER TO ACTION: INTERNATIONAL INSIGHTS INTO THE MENTAL HEALTH POLICY IMPLEMENTATION GAP
(September 19, 10.45-12.15)
RS7.1 The effect of introducing a capitated payment mechanism for psychiatric services in Colorado: unanticipated consequences
R. Warner (USA)
RS7.2 From vision to reality
J. Wallcraft (UK)
RS7.3 Improving the relationship of service providers, carers and users in mental health services
S. Rataemane (South Africa)
RS7.4 Some simple rules for lobbying government
J. Freidin (Australia)
RS7.5 Neglected social determinants in psychiatry
M. Amering (Austria)
RS8. THE IMPACT OF ENVIRONMENTAL ADVERSITY IN CHILDHOOD
(September 19, 10.45-12.15)
RS8.1 Children exposed to war and other disasters
J. Fayyad (Lebanon)
RS8.2 Bullying: characteristics, identification and interventions
Y.S. Kim (USA)
RS8.3 Gene-environment interactions in the face of childhood adversity
M. State (USA)
RS9. IS HIKIKOMORI A JAPANESE CULTURE-BOUND SYNDROME OF SOCIAL WITHDRAWAL OR A GLOBALLY PREVALENT NEW DIAGNOSIS/SYMPTOM ASSOCIATED WITH SOCIOCULTURAL CHANGES?
(September 19, 10.45-12.15)
RS9.1 Hikikomori as a clinical concept in psychiatry
M. Tateno (Japan)
RS9.2 Diagnosis of Hikikomori: the challenges and prospects of a disorder of social isolation
A.R. Teo (USA)
RS9.3 Home visit program for detecting, evaluating and treating socially withdrawn youth in Korea
Y.S. Lee, T.Y. Choi (South Korea)
RS9.4 Prevalence, diagnosis and treatment of Hikikomori: psychiatrists’ impressions across cultures
T.A. Kato (Japan)
RS10. CROSS-CUTTING DIMENSIONAL MEASURES IN THE DSM-5
(September 19, 14.45-16.15)
RS10.1 The DSM-5 and the use of cross-cutting dimensional measures in adults
D. Regier (USA)
RS10.2 Cross-cutting scales for child psychiatry
D. Shaffer (USA)
RS10.3 Anticipating DSM-5: innovations and field trials for psychotic disorders
W.T. Carpenter (USA)
RS10.4 DSM-5 neurocognitive disorders: revisions in response to public input and field trials
D. Jeste (USA)
RS10.5 Including functioning and disability concepts in the DSM-5
W. Narrow (USA)
RS11. ARE THERE BIOMARKERS FOR SCHIZOPHRENIA?
(September 19, 14.45-16.15)
RS11.1 Is P300 low amplitude a biomarker for schizophrenia?
S. Galderisi (Italy)
RS11.2 Electrophysiological correlates of negative symptoms/deficit syndrome schizophrenia
N. Boutros (USA)
RS11.3 Resting state networks and the language system in schizophrenia
W. Strik, H. Horn, K. Jann, S. Walther, A. Federspiel, M. Wirth, T. Müller
(Switzerland)
RS12. NEW RESEARCH ON ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
(September 19, 14.45-16.15)
RS12.1 Do stimulants have a protective effect on the development of psychiatric disorders in youth with ADHD? A ten-year follow-up study
J. Biederman (USA)
RS12.2 Genome-wide association scan of attention-deficit/hyperactivity disorder
S. Faraone, for the ADHD GWAS Consortium (USA)
RS12.3 Brain correlates of ADHD behaviors in medication-naive adults with ADHD: a controlled MRI study
N. Makris (USA)
RS12.4 Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS–methylphenidate in adults with ADHD
T. Spencer (USA)
RS13. ENDURING MENTAL HEALTH EFFECTS OF COLONIALISM ON POST COLONIAL PEOPLES
(September 19, 14.45-16.15)
RS13.1 History casts a long shadow: the European scotomata of the mental health effects of colonialism
J. Guzder (Canada)
RS13.2 Naming the pain: concepts of intergenerational trauma
H. Robertson-Hickling, F.W. Hickling (Jamaica)
RS13.3 The call for an international apology from psychiatric services and professions: emancipating indigenous people with mental illnesses from the "double-whammy" colonization by both imperial powers and psychiatry
A. Rosen (Australia)
RS13.4 Cultural oppression, paranoia and competent diagnosis of schizophrenia in African Americans
A.L. Whaley (USA)
RS14. REWARD SYSTEM DYSFUNCTION IN ADDICTION: GENETIC AND NEUROBIOLOGICAL FOUNDATIONS, IMPACT ON LIFE QUALITY AND THERAPEUTIC INTERVENTIONS
(September 19, 14.45-16.15)
RS14.1 The IMAGEN study: gene x neuroimaging analysis of reward and substance use behaviour in 14-year old adolescents
G. Schumann (UK)
RS14.2 Reward learning dysfunction in addiction
A. Heinz, U. Kluge, A. Beck (Germany)
RS14.3 Quality of life as health indicator among individuals with addiction and complex concurrent disorders
M. Krausz, A. Karow (Canada/Germany)
RS14.4 Resource-oriented treatment of addiction: the Orpheus Program
M. Musalek (Austria)
RS15. CURRENT RESEARCH IN TRANSCULTURAL PSYCHIATRY IN SCANDINAVIAN COUNTRIES
(September 19, 14.45-16.15)
RS15.1 How to increase staff competence in transcultural psychiatry: the Danish experience M. Kastrup (Denmark)
RS15.2 Building bridges for mental health and rehabilitation in an Arctic archipelago
P.R. Jessen, R. Ruud (Norway)
RS15.3 Transcultural telepsychiatry: overcoming barriers in provision of mental health care
D. Mucic (Denmark)
RS15.4 Telepsychiatry in Greenland
P. Bisgaard (Greenland)
RS16. CROSSING THE QUALITY CHASM IN PSYCHIATRY: EXPERIENCES AND LESSONS FROM AROUND THE WORLD
(September 19, 16.30-18.00)
RS16.1 Overview and findings from the International Initiative for Mental Health Leadership (IIMHL) project
H.A. Pincus (USA)
RS16.2 European guidance on quality of mental health services
W. Gaebel (Germany)
RS16.3 Measuring quality of mental health care in Norway
T. Ruud (Norway)
RS16.4 National strategies for measuring mental health quality in Japan
H. Ito, T. Noda, N. Sugiyama, T. Kuroki, S. Matsushita, T. Hirata (Japan)
RS16.5 Mental health quality and outcome measurement and improvement in Scotland
D. Coia (UK)
RS17. NEURAL NETWORKS AND MECHANISMS UNDERLYING ANXIETY: PERSPECTIVES FROM FUNCTIONAL NEUROIMAGING RESEARCH
(September 19, 16.30-18.00)
RS17.1 Stress, emotions and cognition: lessons from studying neurocircuitry in post-traumatic stress disorder
I. Liberzon (USA)
RS17.2 Fear, anxiety, and models of anxiety disorders
C. Grillon (USA)
RS17.3 At the interface of belief and feeling: dysfunction of medial prefrontal cortex during self-assessment and of insula during emotion processing in anxiety
M.P. Paulus, M.B. Stein (USA)
RS17.4 Behavioral and functional magnetic resonance imaging studies of cognitive perturbations in anxiety disorders. A developmental perspective
M. Ernst (USA)
RS18. COERCION AND PSYCHIATRY: RESULTS FROM THE EUNOMIA COLLABORATIVE STUDY
(September 19, 16.30-18.00)
RS18.1 Legal and ethical aspects of research on the use of coercion in psychiatry
T.W. Kallert (Germany)
RS18.2 Outcomes of involuntary hospital admissions
S. Priebe (UK)
RS18.3 Use of coercive measures during involuntary hospitalization: findings from ten European countries
J. Raboch (Czech Republic)
RS18.4 Acute psychopathology as a predictor of prospective global functioning in patients suffering from psychosis: a study in 11 European countries
F. Torres-Gonzales (Spain)
RS18.5 How to improve clinical practice on involuntary hospital admissions of psychiatric patients: results from the EUNOMIA study
A. Fiorillo (Italy)
RS19. ADVANCES IN HIV MENTAL HEALTH AND PREVENTION INTERVENTIONS
(September 19, 16.30-18.00)
RS19.1 Recognizing variety among male homosexual identities: challenges for behavioral medicine
T. Hall (USA)
RS19.2 A pilot study of a trauma-based HIV risk reduction intervention for Mexican American men with histories of childhood sexual abuse
A. Sciolla (USA)
RS19.3 Should HIV testing be routine for psychiatric patients in inpatient and outpatient settings?
R. Daroff (USA)
RS19.4 A therapeutic writing group for men and women living with HIV/AIDS
A. Peterkin (Canada)
RS20. CURRENT RESEARCH ON TRANSCULTURAL PSYCHIATRY IN CANADA
(September 19, 16.30-18.00)
RS20.1 The mental health of indigenous peoples in Canada
L.J. Kirmayer (Canada)
RS20.2 Cultural psychiatry in the Canadian context: a view from child psychiatry
J. Guzder (Canada)
RS20.3 Social factors and the mental health of diverse populations in Canada: a literature review and synthesis
K. McKenzie (Canada)
RS20.4 Cultural psychiatry training in Canada
L. Dabby (Canada)
RS20.5 The social origins of stigma related to mental illness: preliminary results of an epidemiologic catchment area study in Montreal
D. Pedersen (Canada)
RS21. HOMELESSNESS AND MENTAL ILLNESS
(September 19, 18.15-19.45)
RS21.1 Homelessness and mental illness in the world’s developed countries
C. Caton (USA)
RS21.2 Does active substance use at housing entry impair outcomes in supported housing for chronically homeless persons?
R. Rosenheck, E. Edens, J. Tsai, A. Mares (USA)
RS21.3 Pathways’ housing first: international perspectives on ending homelessness and promoting recovery for people with dual diagnoses
S. Tsemberis (USA)
RS21.4 Promoting social inclusion using implementation science
G. Thornicroft (UK)
RS22. ADVANCES IN NEUROSTIMULATION THERAPIES FOR TREATMENT RESISTANT DEPRESSION
(September 19, 18.15-19.45)
RS22.1 Electroconvulsive therapy in the management of depression: report from the CORE trial
G. Petrides (USA)
RS22.2 Magnetic stimulation therapy for the treatment of depression
M.M. Husain (USA)
RS22.3 Development of deep brain stimulation in the treatment of depression
D. Malone (USA)
RS23. ADVANCES IN PEDIATRIC OBSESSIVE-COMPULSIVE DISORDER
(September 19, 18.15-19.45)
RS23.1 D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder
E.A. Storch, T.K. Murphy, W.K. Goodman, G. Geffken, A. Lewin, A. Henin, J. Micco, S. Sprich, S. Wilhelm, M. Bengston, D. Geller (USA)
RS23.2 Quality of life in youth with obsessive-compulsive disorder
C.W. Lack, E.A. Storch, G.R. Geffken, E.D. Ricketts, T.K. Murphy (USA)
RS23.3 Neuro-executive predictors of cognitive-behavioral treatment response in youth with obsessive-compulsive disorder
A.B. Lewin, J.R. Morgan, M.J. Larson, J. Park, D. Venosa, T.K. Murphy, E.A. Storch (USA)
RS23.4 Impact of disruptive behavior disorders on cognitive-behavioral treatment response in pediatric obsessive-compulsive disorder
G. Geffken, E.A. Storch, M. Larson, T.K. Murphy (USA)
RS24. CURRENT RESEARCH IN TRANSCULTURAL PSYCHIATRY IN FRANCE
(September 19, 18.15-19.45)
RS24.1 Providing mental health care to migrants: the clinical medical anthropology approach adapted to the French mental health system
S. Consoli (France)
RS24.2 Specialized mental health care in France: a genealogy
S. Larchanché (France)
RS24.3 Psychoanalytic perspective and migration
V. Sommer (France)
RS24.4 Psychotherapy and migration: cultural competence as the new paradigm in mental health care in France
R. Bennegadi (France)
RS25. SOCIAL COGNITION IN SCHIZOPHRENIA: FROM THE NEUROBIOLOGICAL BASIS TO CLINICAL REMEDIATION
(September 20, 9.00-10.30)
RS25.1 Economic decision-making in patients with schizophrenia: the role of oxytocin
M. Brüne (Germany)
RS25.2 Functional neuroimaging of theory of mind abilities in patients with schizophrenia
K. Koelkebeck, A. Pedersen, M. Brandt, K. Kueppers, J. Bauer, H. Kugel, P. Ohrmann (Germany)
RS25.3 Multimodal neuroimaging studies of social cognition in schizophrenia
R. Kawada (Japan)
RS25.4 Effect of sport participation on brain activations in schizophrenia
H. Takahashi (Japan)
RS26. HUMAN RIGHTS IN THE CARE OF PSYCHIATRIC PATIENTS
(September 20, 9.00-10.30)
RS26.1 Review of legislation protecting people with mental illness
N. Sartorius (Switzerland)
RS26.2 How to unchain chained mental patients
D. Moussaoui (Morocco)
RS26.3 Psychiatry and the penal system in the USA
N. Stotland (USA)
RS26.4 The WPA as mediator in conflict resolutions on patients’ rights
O. Steenfeldt-Foss (Norway)
RS27. HYPOTHALAMIC-PITUITARY-ADRENAL AXIS ACTIVITY IN DEPRESSION AND CHRONIC FATIGUE SYNDROME
(September 20, 9.00-10.30)
RS27.1 Hypocortisolism in chronic fatigue syndrome: causes, consequences and clinical relevance
A.J. Cleare (UK)
RS27.2 The role of hypothalamic-pituitary-adrenal axis dysfunction in treatment-resistant depression
M.F. Juruena (Brazil)
RS27.3 Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study
B.W.J.H. Penninx (The Netherlands)
RS27.4 Hypercortisolism and familial vulnerability to depression
Z. Mannie (UK)
RS28. CHILD AND ADOLESCENT MOOD DISORDER: DIAGNOSIS, TREATMENT AND LIFESPAN PROGNOSIS
(September 20, 9.00-10.30)
RS28.1 Diagnosis and treatment of child and adolescent depression
N. Ryan (USA)
RS28.2 Diagnosis and treatment of child and adolescent bipolar disorder
B. Birmaher (USA)
RS28.3 Suicide in young people
D. Shaffer (USA)
RS29. CONTEMPORARY PRACTICE OF PSYCHODYNAMIC PSYCHIATRY IN THE UNITED STATES (organized by the American Academy of Psychoanalysis and Dynamic Psychiatry)
(September 20, 10.45-12.15)
RS29.1 Practice patterns of dynamic psychiatrists in the United States
S. Olarte (USA)
RS29.2 Healthcare research and the interface with psychodynamic understanding of behavior
J. Goethe (USA)
RS29.3 Psychodynamic psychiatrists and psychopharmacology
J. Silvio (USA)
RS29.4 Psychotherapy interventions with adopted children and their families
E. Rothe (USA)
RS30. DEMORALIZATION IN POPULATIONS EXPERIENCING LIFE THREATENING SITUATIONS AND SEVERE ACCULTURATIVE STRESS
(September 20, 10.45-12.15)
RS30.1 Adaptive strategies for the prevention of demoralization in prolonged bicultural conflict and interaction
J. de Figuereido (USA)
RS30.2 The longitudinal course of demoralization and post-traumatic stress disorder following hurricane Mitch
R. Kohn (USA)
RS30.3 Restoring morale among survivors of political torture: a framework for culturally-sensitive assessment and treatment
J.G. Griffith (USA)
RS30.4 Mental and physical health of refugees recently arrived in a New England city
P. Zimbrean, S. Mourra, A. Oteo, A. Annamalai (USA)
RS31. THE RIGHTS OF WOMEN PSYCHIATRIC PATIENTS
(September 20, 10.45-12.15)
RS31.1 The rights of women psychiatric patients: a review
D.E. Stewart (Canada)
RS31.2 The declaration of Caracas, the reform of mental health services and the rights of women in Latin America
M.B. Rondon (Peru)
RS31.3 Rights issues in women in Pakistani psychiatric hospitals
U. Niaz (Pakistan)
RS32. EMOTIONAL DYSFUNCTIONS IN THE PATHWAY TO PSYCHOSIS AND AS A DETERMINANT OF OUTCOME IN THE CRITICAL PERIOD
(September 20, 10.45-12.15)
RS32.1 Emotional dysfunction in psychosis: more cause than comorbidity?
M. Birchwood (UK)
RS32.2 The bidirectional relationship between subclinical positive psychotic experiences and coping in adolescents
A. Lin, J.T.W. Wigman, W.A.M. Vollebergh, J. van Os, B. Nelson, G. Baksheev, J. Ryan, Q.A.W. Raaijmakers, A. Thompson, A.R. Yung (Australia/The Netherlands/UK)
RS32.3 Attributional and emotional dysfunctions as epiphenomenic sensitization factors for psychotic-like experiences in young adults with social anxiety disorder
M. Armando, P. Girardi, M. Monducci, V. Righetti, C. Dario, R. Saba, S. Vicari, M. Birchwood, P. Fiori Nastro (Italy/UK)
RS32.4 Attributions of power and affiliation and their impact on the depressive and suicidal thinking of people who hear voices
C. Connor, M. Birchwood (UK)
RS33. PREVENTION AND MANAGEMENT OF MENTAL HEALTH CONSEQUENCES OF CHILDHOOD TRAUMA
(September 20, 10.45-12.15)
RS33.1 Childhood trauma: early identification and intervention
R. Pynoos (USA)
RS33.2 The impact of early parental separation and loss
C. Zeanah (USA)
RS33.3 Community interventions for traumatized children and adolescents
E. Caffo (Italy)
RS34. CURRENT RESEARCH ON TRANSCULTURAL PSYCHIATRY IN CARIBBEAN COUNTRIES
(September 20, 10.45-12.15)
RS34.1 Resilience and social capital in African Caribbean mental health
H.A. Robertson Hickling, F.W. Hickling (Jamaica)
RS34.2 The exclusion index: psychopathology among native-born black clients in Britain
A. Burke (UK)
RS34.3 Consultation challenges of the Caribbean family in the diaspora: a child and family perspective
J. Guzder (Canada)
RS34.4 Through the looking glass of migration: social disadvantage, inequality and mental illness
G. Hutchinson (Trinidad)
RS35. THE HEART AND BRAIN CONNECTION: DEPRESSION, ANXIETY AND CARDIOVASCULAR DISEASES
(September 20, 14.45-16.15)
RS35.1 Heartache and heartbreak: the curious relationship between depression and heart disease
C.B. Nemeroff (USA)
RS35.2 Stress and inflammation: the link between anxiety, depression and cardiovascular diseases
L. Carvalho (UK)
RS35.3 The panic-heart connection
G. Perna, R. Menotti, M. Grassi, D. Caldirola (Italy)
RS35.4 Impaired cytokine and cytokine receptor secretions in depressive and anxious disorders: a cause or an effect?
F. Brambilla, G. Perna, S. Po (Italy)
RS36. PROPOSALS FOR THE ICD-11 CLASSIFICATION OF MENTAL DISORDERS IN PRIMARY CARE
(September 20, 14.45-16.15)
RS36.1 The diagnosis and management of depression and anxiety in primary care: the need for a different framework
K.S. Jacob (India)
RS36.2 Emotional distress in primary care in Brazil: idioms, patterns and classification
S. Fortes (Brazil)
RS36.3 Developing a classification system for primary care: ICD-11PC
L. Gask (UK)
RS36.4 Bodily distress disorders
M. Rosendal (Denmark)
RS37. CRITICAL TIME INTERVENTION FOR PERSONS WITH MENTAL ILLNESS: RECENT DEVELOPMENTS IN THE US, UK, EUROPE AND LATIN AMERICA
(September 20, 14.45-16.15)
RS37.1 Critical time intervention: background, model and evidence
D. Herman (USA)
RS37.2 Two randomized controlled trials testing critical time intervention in Dutch facilities for homeless people and abused women
J. Wolf (The Netherlands)
RS37.3 Critical time intervention in Latin America: adaptation for persons with schizophrenia spectrum disorders in Brazil and Chile
E. Valencia, M. Cavalcanti, G. Lovisi, G. Rojas, R. Alvarado, E. Susser (USA)
RS37.4 Use of critical time intervention for discharged mentally ill prisoners in South London: a pilot randomized controlled trial
G. Thornicroft, M. Jarrett, J. Shaw, for the CTI study group (UK)
RS38. ADVANCES IN CHILD PSYCHIATRY RESEARCH
(September 20, 14.45-16.15)
RS38.1 The long-term course of pediatric bipolar disorder: a five-year longitudinal follow-up study
J. Biederman, J. Wozniak (USA)
RS38.2 Are the children who present to the outpatient clinics with “manic symptoms” bipolar?
B. Birmaher (USA)
RS38.3 Cognitive-neuroanatomical correlates of attention: implications for clinical practice
R. Vela (USA)
RS38.4 Update on ADHD neuroimaging: focus on magnetoencephalography
J. Quintero (Spain)
RS39. CURRENT AND FUTURE TREATMENT STRATEGIES FOR BIPOLAR DISORDER: CLINICAL AND MOLECULAR CLUES
(September 20, 14.45-16.15)
RS39.1 Comparative efficacy of existing antimanic agents: an evidence-based assessment
E. Vieta (Spain)
RS39.2 Placebo-related response in clinical trials of bipolar mania: how does it affect trial results and what can be done to minimize it?
A. Yildiz (Turkey)
RS39.3 Oxidative damage to biomolecules as a potential therapeutic target for bipolar disorder
C. Andreazza (Canada)
RS39.4 Glutamatergic modulation as a potential therapeutic target for mood disorders
D. Öngür (USA)
RS40. EVOLUTIONARY FOUNDATIONS FOR PSYCHIATRIC NOSOLOGY
(September 20, 16.30-18.00)
RS40.1 How an evolutionary approach can clarify diagnosis of emotional disorders
R. Nesse (USA)
Rs40.2 An integrative conceptual approach to psychiatric nosology
D. Stein (South Africa)
RS40.3 Teaching the evolutionary basis of nosology to psychiatrists and psychiatry students
T. Baptista (Venezuela)
RS41. ESSENTIAL TOOLS FOR DEVELOPING COMMUNITY MENTAL HEALTH SERVICES IN LOW AND MIDDLE INCOME COUNTRIES
(September 20, 16.30-18.00)
RS41.1 Tools for user and family involvement
M. Amering (Austria)
RS41.2 Tools for managing services and working with patients
H. Katschnig (Austria)
RS41.3 A tool for organizing anti-stigma actions in schools
R. Sfetcu (Romania)
RS41.4 TRIPS-2: an interactive tool for recognizing depression, anxiety and alcohol disorders in primary care
C. Oana (Romania)
RS42. NON-PHARMACOLOGIC INTERVENTIONS FOR MILD COGNITIVE IMPAIRMENT
(September 20, 16.30-18.00)
RS42.1 The case for cognitive exercises
G. Smith (USA)
RS42.2 The case for cognitive compensation strategies
M. Greenaway (USA)
RS42.3 The case for physical exercise and cognitive health
D. Locke (USA)
RS42.4 The case for education and support groups
J. Fields (USA)
RS43. THE INTERNATIONAL STUDY OF STUDENT CAREER CHOICE IN PSYCHIATRY (ISoSCCiP)
(September 20, 16.30-18.00)
RS43.1 ISoSCCiP project phase 1: systematic literature review
K.A. Seed, G. Lydall, A. Malik, R. Howard, D. Bhugra (UK)
RS43.2 ISoSCCiP project phase 2: international arm
A. Malik, K.A. Seed, G. Lydall, R. Howard, D. Bhugra (UK)
RS43.3 ISoSCCiP project phase 3: UK national arm
G. Lydall, K. Seed, A. Malik, R. Howard, D. Bhugra, N. Halder, C. Hadjidemetriou (UK)
RS44. CURRENT RESEARCH ON TRANSCULTURAL PSYCHIATRY IN ENGLAND AND IN THE NETHERLANDS
(September 20, 16.30-18.00)
RS44.1 Conceptualizations of mental illness and help seeking among British Bangladeshis
S. Dein (UK)
RS44.2 Culture, autism and offending
K. Dein (UK)
RS44.3 The influence of culture on diagnostics: analysis of the use of the cultural formulation of diagnosis
H. Rohlof, S. Groen, R. van Dijk, R. Starmans (The Netherlands)
RS44.4 Received and perceived social support as mediators of the relationship between length of stay and psychopathology, disability and quality of life among Iraqi asylum seekers in the Netherlands
C. Laban, I. Komproe, H. Gernaat, J. De Jong (The Netherlands/USA)
RS44.5 Integration of Polish immigrants in the Netherlands: the experience of a Polish mental health care centre in Amsterdam
I. Smoktunowicz, A. Grochowska (The Netherlands)
RS45. GENDER DIFFERENCES IN BIPOLAR DISORDER WITH COMORBID ALCOHOL USE DISORDERS: IMPLICATIONS FOR FUTURE CLINICAL RESEARCH AND TREATMENT
(September 20, 16.30-18.00)
RS45.1 Utilization of residential alcoholism treatment in bipolar disorder
D. Hall-Flavin, T. Schneekloth, L. Loukianova, V. Karpyak, J. Biernacka, D. Mrazek, M. Frye (USA)
RS45.2 Characterizing gender difference in comorbid bipolar disorder and alcoholism
I. Salloum, A. Douaihy, L. Kirisci (USA)
RS45.3 A 2-year follow-up of treated and untreated bipolar and depressed alcoholics
C. Farren, S. McElroy (Ireland/USA)
RS46. PARENTHOOD AND MENTAL HEALTH: A BRIDGE BETWEEN INFANT AND ADULT PSYCHIATRY
(September 20, 18.15-19.45)
RS46.1 The impact of stress during pregnancy
M. Keren (Israel)
RS46.2 Screening for perinatal mental disorder: a review of the thirty year history of the Edinburgh Postnatal Depression Scale
J. Cox (UK)
RS46.3 Being a disabled parent: the impact on family life
S. Hollins (UK)
RS46.4 Single parenthood: its impact on parenting the infant
S. Tyano (Israel)
RS47. IMPULSIVITY AND IMPULSIVE BEHAVIORAL DYSCONTROL: FROM CLINICAL ISSUES TO NEUROCOGNITIVE ASSESSMENT
(September 20, 18.15-19.45)
RS47.1 Impulsivity and aggressiveness in borderline personality disorder: results of a factor analysis
S. Bellino, P. Bozzatello, F. Bogetto (Italy)
RS47.2 Pathological gambling and impulse control disorders: clinical characteristics and treatment approach
S. Pallanti, S. Bernardi (Italy/USA)
RS47.3 Drug treatment of impulsivity in borderline personality disorder: the resuts of a Cochrane Collaboration review
J. M. Stoffers, B.A. Völlm, K. Lieb (Germany/UK)
RS47.4 Impulsivity and executive functions in substance addiction
A. Verdejo-García (Spain)
RS48. SPIRITUALITY AND QUALITY OF CARE IN OLD AGE PSYCHIATRY
(September 20, 18.15-19.45)
RS48.1 Impact of spirituality on quality of care of the aged in traditional vs. transitional family in Serbia
A. Milicevic Kalasic, D. Markovic Zigic, N. Todorovic, M. Vracevic (Serbia)
RS48.2 Spirituality and mental health in old age
C.A de Mendonça Lima, J.L. Gouveia (Portugal)
RS48.3 Spiritual caring activities in nursing homes in Turkey
I. Icelli (Turkey)
RS48.4 Spirituality, religion and dementia
J. Leszek (Poland)
RS48.5 Impact of spirituality on the quality of end-of-life care in the elderly
N. Tataru (Romania)
RS49. TRANSCULTURAL PSYCHIATRY IN THE GERMAN-SPEAKING COUNTRIES
(September 20, 18.15-19.45)
RS49.1 Transcultural psychiatry and psychotherapy at the Psychiatric University Hospital, Zurich
B. Kuechenhoff (Switzerland)
RS49.2 National suicide rates and attitudes toward motives for suicide
T. Stompe, K. Ritter, and the Research Group on Culture and Suicide (Austria)
RS49.3 Culture, birth order and schizophrenia
G. Ortwein-Swoboda, H.R. Chaudhry, S. Gschaider, E.S. Idemudia, H. Karakula, N. Okribelashvili, T. Stompe (Austria/Pakistan/Namibia/Poland/Georgia)
RS49.4 Culture and the epidemiology of schizophrenia subtypes: theoretical considerations and results of the International Study of Psychotic Symptoms in Schizophrenia
D. Holzer, H. Karakula, P. Rudaleviciene, N. Okribelashvili, H.R. Chaudhry, E.E. Idemudia, S. Gschaider, T. Stompe (Austria/Poland/Lithuania/Georgia/Pakistan/Namibia)
RS50. IDENTIFICATION AND MANAGEMENT OF THE DHAT SYNDROME
(September 20, 18.15-19.45)
RS50.1 The Dhat syndrome: a cultural perspective
T.S.S. Rao (India)
RS50.2 The Dhat syndrome: clinical picture
A. Avasthi (India)
RS50.3 The Dhat syndrome: assessment and management
S. Grover (India)
RS51. DEVELOPMENTS IN THE CLASSIFICATION OF PERSONALITY DISORDER
(September 21, 9.00-10.30)
RS51.1 The central domains of personality pathology in psychiatric patients
R. Mulder (New Zealand)
RS51.2 Classifying personality disorder according to severity
M. Crawford (UK)
RS51.3 Proposed changes to the classification of personality disorder in DSM-5
A. Skodol (USA)
RS51.4 Preliminary findings from field trials of ICD-11
P. Tyrer (UK)
RS52. BIPOLAR DISORDER: IDENTIFICATION AND HEALTH CARE UTILIZATION PATTERNS
(September 21, 9.00-10.30)
RS52.1 Direct costs of bipolar disorder compared to other chronic conditions: an employer-based health plan analysis
M. Frye, M. Williams, N. Shah, A. Wagie, D. Wood (USA)
RS52.2 Screening and identifying bipolar disorder in primary care: can it impact health care utilization patterns?
M. Williams, N. Shah, A. Wagie, D. Wood, M. Frye (USA)
RS52.3 Feasibility of one-day training programs in bipolar disorder detection for general practitioners and clinical psychologists
S. Strejilevich (Argentina)
RS52.4 Mood state and reproductive health in bipolar women
E. Marengo (Argentina)
RS53. NEW CHALLENGES AND NEW SOLUTIONS FOR EARLY CAREER PSYCHIATRISTS: THE ROLE OF THE WPA (organized by the WPA Early Career Psychiatrists Council)
(September 21, 9.00-10.30)
RS53.1 Contemporary psychiatric training around the world
F. Picon, H. Elkholy, A. Fiorillo, Z. Lattova (Brazil/Egypt/Italy/Czech Republic)
RS53.2 Early career psychiatrists in Africa and Middle East: training and unmet needs
H. Elkholy (Egypt)
RS53.3 Training in psychiatry in Central and Eastern European countries
Z. Lattova (Czech Republic)
RS53.4 The evolving role of young psychiatrists: an Australasian perspective
P. Brahmbhatt (Australia)
RS53.5 The WPA initiatives for early career psychiatrists
A. Fiorillo, Z. Lattova, P. Brahmbhatt, H. Elkholy, F. Picon (Italy/Czech Republic/Australia/Egypt/Brazil)
RS54. CURRENT RESEARCH ON THE INDIVIDUAL PLACEMENT AND SUPPORT (IPS) MODEL OF SUPPORTED EMPLOYMENT
(September 21, 10.45-12.15)
RS54.1 The implementation of individual placement and support in Europe
T. Burns (UK)
RS54.2 Costs and cost-effectiveness of the individual placement and support model of supported employment: a review of the literature
E. Latimer (Canada)
RS54.3 Individual placement and support and first episode psychosis
S. Singh, M. Rinaldi, R. Perkins, K. McNeil, N. Hickman, F. Jonsson (UK)
RS54.4 The Social Security Administration's Mental Health Treatment Study
R. Drake (USA)
RS55. IMPROVING EFFICACY AND TOLERABILITY OF ANTIDEPRESSANTS IN CLINICAL PRACTICE
(September 21, 10.45-12.15)
RS55.1 Combination of antidepressants from treatment initiation: new treatment strategy in clinical practice?
P. Blier (Canada)
RS55.2 The role of pharmacogenetics in the efficacy and tolerability of antidepressants
A. Schosser (Austria)
RS55.3 Safety of amisulpride in combination with antidepressants in common clinical practice
E. Ceskova, J. Suchopar, Z. Priborska (Czech Republic)
RS55.4 Drug surveillance and safety in German-speaking hospital care
S. Kasper, A. Konstantinidis (Austria)
RS56. IMPULSIVITY AND BRAIN FUNCTION IN ADDICTIONS
(September 21, 10.45-12.15)
RS56.1 White matter and impulsivity in drug addiction
F.G. Moeller, J.L. Steinberg, S.D. Lane, L.A. Kramer, N. Rathnayaka, P.A. Narayana (USA)
RS56.2 Neither bipolar nor obsessive-compulsive: pathological buyers are impulsive acquirers
H. Tavares, T.Z. Filomensky (Brazil)
RS56.3 Impulsivity in non-substance and substance addictions
M.N. Potenza (USA)
RS56.4 Cocaine use affects brain myelin
P.A. Narayana, J. Herrera. J.L. Steinberg, F.G. Moeller (USA)
RS57. ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: DIAGNOSIS AND TREATMENT ACROSS THE LIFESPAN
(September 21, 10.45-12.15)
RS57.1 Diagnostic strategies for attention-deficit/hyperactivity disorder
F.X. Castellanos (USA)
RS57.2 Dysfunction in cognition and executive function in attention deficit/hyperactivity disorder
M. Battaglia (Italy)
RS57.3 Short-term successes and long-term challenges in treatment of attention deficit/hyperactivity disorder
L. Greenhill (USA)
RS58. PREDICTING FEAR CONDITIONING AND ITS EXTINCTION FROM BIOLOGICAL AND PSYCHOLOGICAL MEASURES
(September 21, 10.45-12.15)
RS58.1 Prefrontal-amygdala circuits mediating extinction of fear
G.J. Quirk (Puerto Rico)
RS58.2 Genetics of fear extinction: a novel mouse model
A. Holmes (USA)
RS58.3 Functional reactivity of the fear extinction network to safe stimuli may be predicted by its resting metabolic activity in the human brain
M.R. Milad (USA)
RS58.4 Neuropsychological tests as predictors of fear conditioning and extinction
K.G. Martinez (Puerto Rico)
RS59. DISSEMINATION OF THE INDIVIDUAL PLACEMENT AND SUPPORT (IPS) MODEL OF SUPPORTED EMPLOYMENT
(September 21, 14.45-16.15)
RS59.1 Dissemination of individual placement and support in Italy: problems and opportunities
A. Fioritti, R. Sabatelli, D. Manchisi, D. Piegari, N. Dell'Alba, V. Trono (Italy)
RS59.2 Individual placement and support research and development in early psychosis in Australia
E. Killackey (Australia)
RS59.3 Individual placement and support model of supported employment in the United States
D. Becker (USA)
RS59.4 Individual placement and support in the UK
B. Grove (UK)
RS60. RELIGION, SPIRITUALITY AND PSYCHIATRY
(September 21, 14.45-16.15)
RS60.1 Religious and non-religious worldviews
P.J. Verhagen (The Netherlands)
RS60.2 Differential diagnosis between spiritual experiences and mental disorders
A. Moreira-Almeida, A. Menezes Jr. (Brazil)
RS60.3 Twelve year history of depression, image of God and religious coping: results from the Longitudinal Aging Study Amsterdam
A. Braam, J. Schaap Jonker, M. van der Horst, B. Steunenberg, A. Beekman, W. van Tilburg, D. Deeg (The Netherlands)
RS60.4 Understanding Geetopdesh: enhancing skills in the practice of psychotherapy
M. Sameer (India)
RS61. USING NEUROENDOCRINOLOGY TO UNDERSTAND PATHOGENESIS AND DEVELOP NEW TREATMENTS
(September 21, 14.45-16.15)
RS61.1 The effect of early life trauma on the corticotropin-releasing factor circuits: implications for the pathophysiology and treatment of mood and anxiety disorders
C.B. Nemeroff (USA)
RS61.2 Neuropeptides in schizophrenia: focus on environmental risk factors
A. Shrivastava (Canada)
RS61.3 Cortisol in depressive subtypes: status of glucocorticoid antagonists
A.F. Schatzberg (USA)
RS61.4 Nonhuman primate models to study HPA and CRF dysregulation in anxiety and depression
N.H. Kalin (USA)
RS61.5 Update on regulation of the HPA axis: focus on cognitive and neurobiological approaches
G. Tafet (Argentina)
RS62. CURRENT RESEARCH IN TRANSCULTURAL PSYCHIATRY IN THE UNITED STATES
(September 21, 14.45-16.15)
RS62.1 Research in cultural psychiatry in the United States over the last ten years
R. Kohn, R. Wintrob (USA)
RS62.2 Adapting multifamily groups to improve treatment adherence in Latinos with schizophrenia
A. Kopelowicz (USA)
RS62.3 “Sociocultural issues” in psychiatry residency training accreditation standards in the United States: present and future
F. Lu (USA)
RS62.4 To be or not to be? Cultural components in the development of DSM-5
R. Alarcón (USA)
RS62.5 A cross-national multi-center study of depression, demoralization and functional impairment in cancer patients
J.M. de Figueiredo (USA)
RS63. RECENT TRENDS AND HOT ISSUES CONCERNING PSYCHIATRIC TRAINING AND EARLY PHASES OF PSYCHIATRIC CAREER
(September 21, 14.45-16.15)
RS63.1 Leadership, role and administrative issues in early phases of psychiatric career
J.N. Beezhold (UK)
RS63.2 Learning to lead multidisciplinary teams: lessons for young psychiatrists
A. Malik (UK)
RS63.3 Well-being and mental health of psychiatry residents
N. Jovanovic (Croatia)
RS63.4 The challenges of psychiatric training in low- and middle-income countries: a focus on Latin America
G. Rivera (Bolivia)
RS63.5 Development and future perspectives of European young psychiatrists
D. Giacco, A. Fiorillo, U. Volpe (Italy)
RS64. CURRENT FACTS AND TRENDS IN THE TREATMENT OF SCHIZOPHRENIA
(September 21, 16.30-18.00)
RS64.1 Response rates for different dimensions of psychosis: future developments
W. Gaebel (Germany)
RS64.2 Why are “depots” back?
V. Larach-Walters (Chile)
RS64.3 Social capital, pathway to care and duration of untreated psychosis: findings from a low and middle income country context
J.K. Burns, J.B. Kirkbride, K. Jhazbhay, R.A. Emsley (South Africa/UK)
RS64.4 Time to antipsychotic response: when to consider a patient refractory and what to do
H. Elkis (Brazil)
RS65. PRESENT AND CLOSE FUTURE OF ALZHEIMER’S DISEASE TREATMENT
(September 21, 16.30-18.00)
RS65.1 Clinical practice with anti-dementia drugs: revised consensus
J.T. O'Brien (UK)
RS65.2 Safety considerations on magnetic resonance imaging in anti-amyloid trials: a review
P. Scheltens (The Netherlands)
RS65.3 Development of passive immunotherapy: limitations and chances
C. Hock (Switzerland)
RS65.4 Active anti-amyloid immunotherapy in Alzheimer’s disease with CAD 106
J.-M. Orgogozo (France)
RS66. IMMUNE-MEDIATED BODY-MIND INTERACTIONS IN MOOD DISORDERS: DIAGNOSTIC AND THERAPEUTIC PERSPECTIVES
(September 21, 16.30-18.00)
RS66.1 The diagnostic and prognostic value of monocyte gene expression and T cell phenotypic profiles in mood disorders
H.A. Drexhage, R.C. Drexhage, K. Weigelt, E. Mesman, M. Hillegers, L. Carvalho, V. Bergink, W.A. Nolen (The Netherlands)
RS66.2 Autonomic nervous system and immune interaction in depression
A. Halaris (USA)
RS66.3 Biochemical and genetic aspects of immune and kynurenine markers in mood disorders
A.M. Myint, M. Rothermundt, M.J. Schwarz, M. Muelbacher, S. Claes (Germany/Austria/Belgium)
RS66.4 Post-mortem studies on the role of microglia in depression: is there evidence for a cerebral activation of the mononuclear phagocyte system?
J. Steiner, A.M. Myint (Germany)
RS67. MENTAL ILLNESSES IN TRADITIONAL SOCIETIES: CULTURE SPECIFIC OR CULTURAL VARIANTS?
(September 21, 16.30-18.00)
RS67.1 Ancient civilization concepts of mental health and illness
V. Varma (USA)
RS67.2 Relationship between acute psychosis and schizophrenia: evidence from research
S. Malhotra, S. Malhotra (India)
RS67.3 The semantics, syntactics, and pragmatics of culture specificity and boundedness
N. Gupta (UK)
RS67.4 Does Dhat syndrome convey anything meaningful?
S. Malik, N. Ahuja (India/UK)
RS68. CANADIAN NETWORK FOR MOOD AND ANXIETY TREATMENTS (CANMAT) BIPOLAR DISORDER GUIDELINES: A CONSTANT EVOLUTION
(September 21, 18.15-19.45)
RS68.1 CANMAT guidelines for evidence based management of mania
L. Yatham (Canada)
RS68.2 CANMAT guidelines for the management of bipolar I depression
A. Schaffer (Canada)
RS68.3 The management of bipolar II disorder: new advances in treatment
D. Bond (Canada)
RS68.4 Treatment of comorbidity in individuals with major depressive disorder or bipolar disorder: therapeutic approaches to the “real world” patient
R. McIntyre (Canada)
RS69. RELATIONSHIP OF STIGMA, NEEDS AND INFORMAL CARE TO OUTCOME OF SEVERE SCHIZOPHRENIC DISORDERS: THE MARISTAN STUDY
(September 21, 18.15-19.45)
RS69.1 The MARISTAN study. Phase I: the qualitative approach
F. Torres-González, A. Runte Geidel, C. Antonioli, J.M. Caldas de Almeida, M.B. King (Spain/Argentina/Portugal/UK)
RS69.2 MARISTAN scale for stigma in people that suffer from schizophrenia and related disorders: psychometric properties
S. Saldivia, M. King, F. Torres, M. Xavier, C. Antonioli, D. Ballester, A. Runte, P. Grandon, R. Melipillan (Chile/UK/Spain/Portugal/Argentina/Brazil)
RS69.3 MARISTAN scale for needs and informal care in people that suffer from schizophrenia and related disorders: psychometric properties
D. Ballester, C. Antonioli, P. Grandon, M. King, A. Runte, S. Saldivia, F. Torres, M. Xavier, R. Melipillan (Brazil/Argentina/Chile/UK/Spain/Portugal)
RS69.4 Relationship of stigma, needs and informal care to outcome of severe schizophrenic disorders: design of phase III of MARISTAN study
B. Vicente, D.A. Ballester, J.M. Caldas de Almeida, E. Galende, M.B. King, S. Saldivia, F. Torres-González (Chile/Brazil/Portugal/Argentina/UK/Spain)
RS70. RESILIENCE AND VULNERABILITY FACTORS IN DEPRESSION: IMPLICATIONS FOR THERAPEUTIC INTERVENTIONS
(September 21, 18.15-19.45)
RS70.1 Neuroendocrine molecular regulation of stress, anxiety and depression
E. Arzt (Argentina)
RS70.2 Brain-derived neurotrophic factor: state of the art in depression and prediction of therapy response
A. Eckert (Switzerland)
RS70.3 Neuroendocrine and sleep regulation as predictors of healthy mental development in children and predictors of course of depression in adults
M. Hatzinger (Switzerland)
RS70.4 Seeking for new targets and circuits in depression: from molecular screenings to in vivo genetic dissection in mutant mice
D. Refojo (Germany)
RS71. THE ALEXITHYMIA CONSTRUCT: HISTORY, RECENT DEVELOPMENTS AND FUTURE DIRECTIONS
(September 21, 18.15-19.45)
RS71.1 An overview of alexithymia
G.J. Taylor (Canada)
RS71.2 Alexithymia: from theory to clinical practice
H.A. Lunazzi (Argentina)
RS71.3 Alexithymia, personality, and the DSM-5
R.M. Bagby (Canada)
RS71.4 Perspectives on the future of alexithymia research based on recent fMRI and self-report alexithymia investigations
G. Komaki (Japan)
RS72. MENTAL HEALTH CARE IN THE BALKANS AND EASTERN EUROPE (organized by the Psychiatric Association for Eastern Europe and the Balkans)
(September 21, 18.15-19.45)
RS72.1 Towards reform of psychiatry and psychiatrists
D. Lecic-Tosevski (Serbia)
RS72.2 Toward reform of mental health services in Turkey
P.G. Gökalp, F. Karadag, A.G. Hariri, O. Saatcioglu, B. Aslantas, E. Ertekin (Turkey)
RS72.3 Mental health care provision in Greece: the unfinished reform
G.N. Christodoulou, D.N. Ploumpidis, N.G. Christodoulou, D. Anagnostopoulos (Greece)
RS72.4 Advances and restrictions of psychiatric reform in Russia
V. Krasnov (Russia)
RS73. CURRENT TRENDS IN THE DEVELOPMENT OF THE CONCEPT OF SCHIZOPHRENIA
(September 22, 9.00-10.30)
RS73.1 The new concept of schizophrenia accompanying the “renaming” of the disorder
T. Maruta (Japan)
RS73.2 Dynamic approaches in Russian psychiatry as a basis of classification development
V.N. Krasnov (Russia)
RS73.3 Defining schizophrenia: from Kraepelin to DSM-5
R. Tandon (USA)
RS73.4 “Schizophrenia”: common issues in conceptualizing severe psychotic disorders from Kraepelin and Bleuler to 21st century psychiatry
P. Hoff (Switzerland)
RS74. MIGRATION AND MENTAL HEALTH
(September 22, 9.00-10.30)
RS74.1 Migration and mental health: an overview
D. Bhugra (UK)
RS74.2 The mental health of refugees: from asylum to advocacy
L.J. Kirmayer (Canada)
RS74.3 Migration and risk of depression by gender in Sardinian studies
M.G. Carta, M.F. Moro, N. Rudas (Italy)
RS74.4 Mental health of migrant workers in China: benefits and costs of moving to the cities
D.F. Wong (China)
RS75. NEW ADVANCES IN CLINICAL RESEARCH ON EATING DISORDERS
(September 22, 9.00-10.30)
RS75.1 Evidence-based treatments for eating disorders
A. Claudino (Brazil)
RS75.2 Guided (self) help and other innovative approaches to eating disorders
C. Thiels (Germany)
RS75.3 Psychiatric co-morbidity of adult eating disorder patients
C. Rausch Herscovici (Argentina)
RS75.4 Prognostic factors in children and adolescents with eating disorders in a Brazilian public service
V. Pinzon, B. Fleitlich-Bilyk (Brazil)
RS76. CULTURE AND DEPRESSION: DETERMINANTS OF MENTAL HEALTH IN DIVERSE COMMUNITIES
(September 22, 9.00-10.30)
RS76.1 Does a retrospective lifetime measure of major events have a half-life?
D. Lloyd (USA)
RS76.2 The long-term trajectory of depression among Latinos in primary care and its relationship to depression care disparities
A. Interian, A. Ang, M.A. Gara, M.A. Rodriguez, W.A. Vega (USA)
RS76.3 Lifetime and 12-month prevalence of DSM-IV major depressive disorder among older African Americans, black Caribbeans, and non-Hispanic whites: results from the national survey of American life
M.P. Aranda, D.H. Chae, K.D. Lincoln, R.J. Taylor, L.M. Chatters, A. Toler Woodward (USA)
RS76.4 Race and sociodemographic differences in comorbid depression and obesity among black and white Americans
K.D. Lincoln (USA)
RS77. BEST PRACTICE IN COMMUNITY MENTAL HEALTH PARTNERSHIPS IN THE ASIA-PACIFIC REGION
(September 22, 9.00-10.30)
RS77.1 Asia-Pacific Community Mental Health Development Project: stage 2
C. Ng, J. Fraser, D. Paroissien, M. Goding, B. Ryan (Australia)
RS77.2 The biggest trial of mental health service transformation in China: experiences, partnerships and expectations
X. Yu, J. Liu, H. Ma (China)
RS77.3 Participation of religious organizations in mental health care in Thailand
A. Benjaponpitak, T. Mekvilai (Thailand)
RS78. CO-MORBIDITY OF DEPRESSION AND DIABETES: PROBLEMS FOR SCIENCE AND CONSEQUENCES FOR PRACTICE
(September 22, 10.45-12.15)
RS78.1 Epidemiology and pathogenesis of co-morbid depression and diabetes
O. Gureje (Nigeria)
RS78.2 Treatment interventions for co-morbid depression and diabetes
M. Riba (USA)
RS78.3 Transcultural issues related to co-morbid depression and diabetes
M. Kastrup (Denmark)
RS78.4 Health economics and public health related to co-morbid depression and diabetes
J.J. Gagliardino (Argentina)
RS79. STRENGTHENING HEALTH SYSTEMS: INTEGRATING MENTAL HEALTH AND PRIMARY CARE
(September 22, 10.45-12.15)
RS79.1 The transformation of a traditional network of in- and out-patients into a single integrated service: the Madrid experience
J.J. López-Ibor (Spain)
RS79.2 Process management in psychiatry: the collaboration with primary care
B. Reneses (Spain)
RS79.3 Implementation science: understanding the translation of evidence into practice
M. Tansella, G. Thornicroft (Italy/UK)
RS79.4 Psychiatry and primary care integration: a 21st century imperative
E. Sorel (USA)
RS80. THE NEUROPLASTICITY HYPOTHESIS OF DEPRESSION: NOVEL INSIGHTS INTO THE PATHOPHYSIOLOGY OF DEPRESSION
(September 22, 10.45-12.15)
RS80.1 Antidepressants act by reactivating developmental plasticity in the adult brain
E. Castrén (Finland)
RS80.2 Learning as a model of neural plasticity in depression
C. Nissen, J. Holz, C. Normann (Germany)
RS80.3 Long-term synaptic plasticity in the pathophysiology of depression
C. Normann (Germany)
RS81. PRODROMES AND NEUROPSYCHIATRIC SYMPTOMS IN DEMENTIA: RECENT ADVANCES
(September 22, 10.45-12.15)
RS81.1 Mild cognitive impairment: believe it or not?
R. Allegri (Argentina)
RS81.2 Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients
F. Taragano (Argentina)
RS81.3 The Neuropsychiatric Inventory-Clinician Rating Scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia
J. Kremer (Argentina)
RS82. TREATMENT RESISTANT DEPRESSION: A GLOBAL ROADMAP FOR EFFECTIVE CARE
(September 22, 10.45-12.15)
RS82.1 Treatment resistant depression: clinical guidelines for treatment and prevention
J.F. Greden (USA)
RS82.2 Treatment resistant depression: evidence for effectiveness of psychotherapy and combination treatment
J. Himle, M. Riba (USA)
RS82.3 The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation
S. Sen, K.B. Karg, M. Burmeister, K. Shedden (USA/Germany)
RS82.4 Treatment resistant depression: what did STAR*D teach us about pharmacological strategies for recovery and maintenance
M.E. Thase (USA)
RS83. CURRENT RESEARCH ON TRANSCULTURAL PSYCHIATRY IN RUSSIA
(September 22, 10.45-12.15)
RS83.1 Theoretical and methodological approaches to transcultural psychiatry research in Russia
V. Semke (Russia)
RS83.2 Ethnic factors in the etiology of mental disorders among refugees from the war zone in Chechnya
B.D. Tsygankov, A.I. Bylim (Russia)
RS83.3 Ethnocultural assessment of substance use disorders among ethnic minority populations of Siberia and Russian Far East
N.A. Bokhan, I.E. Kupriyanova, D.I. Kurgak (Russia)
RS83.4 Adaptation of schizophrenic patients in poly-ethnic populations of Siberia
A.V. Semke, L.D. Rakhmazova (Russia)
RS84. DEVELOPMENT AND USE OF STANDARD SETS OF INDICATORS FOR ASSESSING MENTAL HEALTH SYSTEMS
(September 22, 14.45-16.15)
RS84.1 Towards a taxonomy of mental health indicators
A. Bulbena, J.A. Salinas, L. Salvador-Carulla (Spain)
RS84.2 Use of prior expert knowledge to build a brief indicator set to assess regional mental health systems in Spain
M. Martin, M. Roca (Spain)
RS84.3 A brief indicator set from WHO-AIMS to assess the mental health systems of 42 low- and middle-income countries
L. Salvador-Carulla, K. Gilbert (Spain)
RS84.4 DESDE-LTC indicators for comparing mental health areas in Chile and Spain
S. Saldivia, C. Romero (Chile/Spain)
RS85. CULTURAL ASPECTS OF MOOD DISORDERS
(September 22, 14.45-16.15)
RS85.1 Depression from a transcultural perspective: an overview of the WPA educational programme
M. Kastrup (Denmark)
RS85.2 Cultural and personality factors affecting the assessment, diagnosis and treatment of depression
A. Heerlein (Chile)
RS85.3 Cultural differences in the treatment of bipolar disorder: an Arab perspective
T.A. Okasha (Egypt)
RS85.4 Cultural aspects of suicide
D. Moussaoui (Morocco)
RS86. EARLY DIAGNOSIS AND PREDICTION OF OUTCOME IN PSYCHOTIC DISORDERS AT FIRST EPISODE: SOME NEW EVIDENCE
(September 22, 14.45-16.15)
RS86.1 Early case identification and stability of diagnosis in first episode psychosis
A. Malla (Canada)
RS86.2 Neuroimaging and cognitive differentiation of stimulant-induced psychosis from first episode psychosis
P. Tibbo, B. Lichlyter, C. Hanstock, P. Seres, S. Purdon, D. Bernier (Canada)
RS86.3 Neurocognitive and neuroimaging markers of short-term clinical outcome following a first episode of psychosis
M. Lepage (Canada)
RS87. ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND ITS COMORBIDITIES
(September 22, 14.45-16.15)
RS87.1 Genetic studies of ADHD: shared genes contribute to ADHD and comorbid disorders
C.L. Barr, K. Wigg, T. Cate-Carter, L.W. Maureen, E. Kerr (Canada)
RS87.2 ADHD and conduct problems in adolescents
S. Bengi (Turkey)
RS87.3 Comorbidity between ADHD and bipolar disorder
N. Motavalli Mukaddes (Turkey)
RS87.4 Serotonin system gene variants influence impulsivity in ADHD and aggression
J.L. Kennedy, D.J. Mueller, U. Jain, J.H. Beitchman (Canada)
RS88. ADVANCES IN THE NEUROBIOLOGICAL UNDERSTANDING OF SEVERE ADULT PSYCHIATRIC DISEASE: A DEVELOPMENTAL PERSPECTIVE
(September 22, 14.45-16.15)
RS88.1 A developmental perspective on the neurobiology of schizophrenia: a longitudinal cohort study of “prodromal” patients
C. Corcoran (USA)
RS88.2 Do social cognition alterations in schizophrenia represent a developmental phenomenon? A brain imaging and social functioning study in patients and their unaffected siblings
S.M. Guinjoan (Argentina)
RS88.3 A specific pattern of autonomic dysfunction in schizophrenia?
K.-J. Bär (Germany)
RS88.4 The neurobiology of child abuse and neglect: impact on the pathophysiology and treatment of mood disorders
C.B. Nemeroff, L.M. Miller (USA)
RS89. CURRENT RESEARCH ON TRANSCULTURAL PSYCHIATRY IN ASIAN COUNTRIES
(September 22, 14.45-16.15)
RS89.1 Transcultural psychiatric phenomena in Japan: Hikikomori, Otaku and a new type of depression
F. Noda (Canada)
RS89.2 Current research in transcultural psychiatry in Japan
T. Akiyama (Japan)
RS89.3 The development and challenge of transcultural psychiatry in China
J. Yang, X. Zhao, C. Kang (China)
RS89.4 Clinical and pharmacogenetic characteristics of Korean patients with major depressive disorder
M.S. Lee (Korea)
RS90. WOMEN’S MENTAL HEALTH: CLINICAL AND PSYCHOLOGICAL CONSIDERATIONS
(September 22, 16.30-18.00)
RS90.1 Gender and diagnostic biases
C. Leal, A. Oliveras (Spain)
RS90.2 Women in Latin America: where are they going?
S.L. Gaviria (Colombia)
RS90.3 Transference and countertransference in psychotherapy of the borderline patient: are gender differences important?
M.J. de Fahrer (Argentina)
RS90.4 DSM-5 update: focus on gender and ethnic perspectives
J.I. Escobar (USA)
RS91. HOW THE MENTALLY ILL ARE PORTRAYED IN PRINT MEDIA AND WHAT WE CAN DO ABOUT IT: A CENTRAL EUROPEAN PERSPECTIVE
(September 22, 16.30-18.00)
RS91.1 How distorted is the picture of mentally ill people in print media and who is to blame?
A. Nawka, T. Vukusic Rukavina, L. Nawkova, O. Brborovic, Z. Lattova (Czech Republic/Croatia)
RS91.2 Stigma in Central European print media: analysis of the stigmatizing potential of the keywords
T. Vukusic Rukavina, O. Brborovic, A. Nawka, Z. Lattova, L. Nawkova (Croatia/Czech Republic)
RS91.3 Mental illness and aggression in the printed media: is there a link? A Central European perspective
Z. Lattova, A. Nawka, T. Vukusic Rukavina, L. Nawková, N. Jovanovic, O. Brborovic (Czech Republic/Croatia)
RS91.4 Annual “media and health” courses: examples of how health professionals and journalists can improve communication
O. Brborovic, T. Vukusic Rukavina, M. Harapin, G. Pavlekovic, V. Dordevic, S. Oreskovic (Czech Republic/Croatia)
RS92. DUAL DISORDERS IN THE CONTEXT OF NEUROSCIENCES
(September 22, 16.30-18.00)
RS92.1 Depression and comorbid nicotine dependence: neurobiological substrates and treatment implications
U. Busto (Canada)
RS92.2 Treatment of attention-deficit/hyperactivity disorder and subsequent risk of substance use disorder
J. Martinez-Raga (Spain)
RS92.3 Depression and substance use disorders
M. Torrens (Spain)
RS93. ORGANIZED PSYCHIATRY AND LESBIAN, GAY, BISEXUAL AND TRANSGENDER MENTAL HEALTH
(September 22, 16.30-18.00)
RS93.1 Kaiser Permanente lesbian, gay, bisexual and transgendered mental healthcare initiatives
R. Holt (USA)
RS93.2 Practice guidelines for gay, lesbian, bisexual, gender non-conforming and gender discordant youth
S. Adelson (USA)
RS93.3 Lesbian and gay issues and the DSM-5 research agenda
R. Cabaj (USA)
RS93.4 Psychiatric perspectives on same sex marriage, including the position statement of the American Psychiatric Association on same sex marriage
G. Nakajima (USA)
RS94. PSYCHOSOCIAL APPROACHES FOR BETTER MENTAL HEALTH: CHALLENGING ASPECTS OF RUSSIAN EXPERIENCE
(September 22, 16.30-18.00)
RS94.1 The 10-year experience of the Russian first episode psychosis program
I. Gurovich, A. Shmukler, Y. Zaitseva (Russia)
RS94.2 Psychosocial support for outpatients with war related mental disorders in primary health care: the experience of Chechnya
K. Idrisov (Russia)
RS94.3 A comprehensive psychosocial programme for student mental health
M. Kulygina (Russia)
RS94.4 Psychosocial rehabilitation in child psychiatry
E. Koren (Russia)
RS94.5 Sociocultural and regional aspects of suicide prevention
E. Nikolaev (Russia)